How Long Does a Heart Stent Last?

A heart stent is permanent and stays inside the artery for the rest of a patient’s life. It doesn’t wear out, dissolve in most cases, or need routine replacement. Modern drug-eluting stents keep the treated artery open in more than 90% of patients beyond five years. What varies is not the stent itself but whether the artery around it stays clear, which depends on medication, lifestyle, and underlying risk factors.

According to Dr. S. A. Merchant, Advanced Heart Failure Specialist in Mumbai, “Patients often ask when the stent will need changing, and the honest answer is never, because it becomes part of the artery wall within weeks, what we’re really managing after that is the health of the rest of the vessel.”

Yes, the device itself does. Whether the artery around it behaves is a separate question, and that’s where outcomes actually split.

• It becomes part of the artery: Four to six weeks after placement, the vessel lining grows over the mesh and locks it in. After that it can’t shift or migrate, and removing it would mean surgery.
• No expiry on the metal: A stent placed at age 50 is the same stent doing its job at 80. Metal doesn’t degrade inside the body. The only thing that changes is what happens in the artery next to it.
• Restenosis shows up early or not at all: Re-narrowing is the one real threat, and it nearly always appears inside the first 6 to 12 months. Clear that window and the odds of that segment failing fall off sharply.
• Why the medicated coating matters: Bare-metal stents used to re-narrow in 20 to 30% of cases. That was a real problem. The drug coating on today’s stents dropped it to somewhere around 5 to 10%, which is why almost nobody uses the old ones now.

So durability isn’t a worry. Keeping the rest of the vessel healthy is. You can read more about how stenting actually works.

Two people can walk out with the exact same stent and end up in completely different places ten years on. The device rarely explains the gap. What happens afterward usually does.

• Skipping the medication is the big one: Stopping antiplatelet drugs like aspirin or clopidogrel earlier than advised is the most common avoidable cause of stent thrombosis, which is a sudden clot that can kill. The timeline a cardiologist gives isn’t padding.
• Diabetes: Poorly controlled blood sugar speeds up plaque buildup and roughly doubles the restenosis risk. Diabetic patients need closer follow-up, even the ones who feel perfectly fine.
• Smoking undoes the work: Light up again after a stent and new blockages form faster, which cancels out much of what the procedure achieved. Quitting genuinely shifts the long-term outlook, and it’s the one lever entirely in the patient’s hands.
• Fresh plaque somewhere else: A stent treats one spot and does nothing for the rest of the coronary tree. Ignore cholesterol and blood pressure and a brand-new blockage can show up inches from a stent that’s working perfectly.

A stent restores blood flow and buys real time. It doesn’t cure coronary artery disease. Staying on the right heart medications is a big part of protecting it long term.

Dr. S. A. Merchant, DM(Cardiology), MD(MED), DNB(Cardiology), FSCAI(USA), has spent more than 25 years on coronary work, from complex angioplasty and bioresorbable scaffolds to drug-coated balloons and physiology-guided PCI with FFR and IVUS. He’s a founder member and senior consultant at Lilavati Hospital, and the Cleveland Clinic eHealth Research USA lists him among the world’s leading doctors across 143 countries. Placing the stent right is only half the job here. The follow-up plan is what keeps it working for decades.

Patients leave with a clear medication timeline, specific risk-factor targets, and a straight answer on what their stent can and can’t do for them. That gap, between a stent that lasts a lifetime and one that fails in year two, almost always comes down to what happens after the cathlab.

Call +91-9820930389 to book your consultation.

REFERENCE:

1. Austin D, et al. Long-term outcomes of patients receiving drug-eluting stents. PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC2621281/
2. Roh JH, et al. Five-year clinical outcomes of drug-eluting stents. PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC4939495/